EUVIMEDEUVIMED entdecken
Crossref

Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging

Jing Wang iD, Linlin Zhang iD, Xinyu Cui iD, Xiang Xu iD, Rui Guo iD, Kairui Li iD, Li Zhang iD, Bing Xu, Cizhong Jiang iD, Yong Yu iD

Science Immunology · 11.04.2025 · 10 (106)

DOI: 10.1126/sciimmunol.adr2041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 11.04.2025. Verfasst von Jing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University,…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Inflammation, Aging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preserving hematopoietic stem cell (HSC) functionality is essential for maintaining healthy blood and the immune system throughout life. HSC function declines with age; however, the underlying mechanisms are not fully understood. Using an inducible mosaic mouse model to overexpress the transcription factor Bcl11a in the hematopoietic compartment, we found that an aging-related increase in Bcl11a mitigated HSC functional decline, promoted IL-1β production in the bone marrow (BM), and accelerated HSC attrition in a non–cell-autonomous manner. Aging-related inflammation in the BM enhanced Bcl11a and Fc receptor (FcR) expression in HSCs, and FcR signaling induced HSC differentiation. This was counteracted by Bcl11a through repression of Fcer1g . Bcl11a up-regulation promoted IL-1β production in BM myeloid cells, driving inflammation and HSC deterioration. Deletion of Fcer1g , or blocking IL-1β signaling, eliminated this non–cell-autonomous effect on HSC decline. These findings demonstrate that Bcl11a plays a dual role in HSCs during aging not only by cell-intrinsically preserving HSC function but also by promoting BM inflammation and HSC dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsInflammationAgingAnimalsMiceMice, Inbred C57BLInterleukin-1betaReceptors, FcRepressor Proteins

Substanzen

Bcl11a protein, mouseInterleukin-1betaReceptors, FcRepressor Proteins

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Department of Hematology, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Jing Wang, Linlin Zhang, Xinyu Cui, Xiang Xu, Rui Guo, Kairui Li, Li Zhang, Cizhong Jiang, Yong Yu

Zitieren

APA

Wang, J., Zhang, L., Cui, X., Xu, X., Guo, R., Li, K., Zhang, L., Xu, B., Jiang, C., & Yu, Y. (2025). Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging. Science Immunology, 10(106). https://doi.org/10.1126/sciimmunol.adr2041

Vancouver

Wang J, Zhang L, Cui X, Xu X, Guo R, Li K, et al. Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging. Science Immunology. 2025;10(106). doi:10.1126/sciimmunol.adr2041

BibTeX
@article{Wang2025,
  author = {Wang, Jing and Zhang, Linlin and Cui, Xinyu and Xu, Xiang and Guo, Rui and Li, Kairui and Zhang, Li and Xu, Bing and Jiang, Cizhong and Yu, Yong},
  title = {Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging},
  journal = {Science Immunology},
  year = {2025},
  volume = {10},
  number = {106},
  doi = {10.1126/sciimmunol.adr2041}
}
Kostenlos starten →